The UAE Drug Authority (Emirates Drug Establishment) has reviewed key changes in the regulatory framework concerning the advertising of medical goods, specifically introducing the possibility of promoting Prescription Only Medicines (POMs) provided that approved regulatory standards are met.
A Council for Medical Product Advertising Clients was established to implement the latest updates in regulating advertising content and to strengthen compliance with applicable rules and requirements.
Various advertising placement channels were discussed, including print media, audiovisual materials such as billboards, as well as websites, social media platforms, and other digital channels.
The Council meeting took place at Emirates Towers, where industry representatives, partners, and clients gathered to raise stakeholders' awareness about the importance of obtaining permission before publishing or distributing advertising materials.
The application procedure through the advertising licensing system was examined, which includes the necessary supporting documents and advertising content depending on the type of advertisement and the chosen channel, as well as the application review process and submission requirements.
Furthermore, regulatory requirements regarding advertising content were discussed, with special emphasis placed on ensuring accuracy, clarity of information, and the absence of misleading claims.
Advertising materials must comply with the approved product information and its use, and must clearly state any relevant risks or side effects. Participants also reviewed appropriate disclaimers required depending on the product type and target audience, as well as the importance of preventing the encouragement of self-diagnosis or self-medication by the general public without proper medical supervision.
The Council also addressed issues of monitoring and inspecting advertising across various media channels, including mechanisms for handling non-compliant content and coordination with relevant authorities to take action and remove non-compliant materials when necessary.
The requirement to obtain approval from the Emirates Drug Establishment (EDE) before publishing or distributing any advertisement was reaffirmed, as well as adhering to the rules and regulations governing advertising claims and promotion methods, including the prohibition of advertising, promoting, or endorsing medical products through social media influencers.
The meeting also provided an opportunity for dialogue with clients regarding their experience working with the service and practical aspects of submitting applications. Participants shared questions, feedback, and suggestions, while discussions explored ways to refine procedures and simplify application requirements, contributing to continuous service improvement and increased overall customer satisfaction.
The Council was held as part of Emirates Drug Establishment's ongoing efforts to expand communication channels with stakeholders and involve them in developing services within its purview, supporting advertising compliance, public protection, and promoting the safe use of medical products.



